OpenAlex
PricingAboutJobs
Log inGet started
Work

MM-915: Comparative Outcomes of CD38 Antibody–Containing Four-Drug Induction Strategies vs Standard Triplet Therapy in High-Risk Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

HTML

Year: 2026
Type: conference-abstract
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/s2152-2650(26)02957-5
Authors: Jasvindar Kumar, Manohar Lal, Vinesh Kumar, Jaish Kumar, Medhansh Biradar, Imandi Venkata Lakshmi, FNU Raja
Institutions: Bassett Medical Center, Saint Michael's Medical Center, All India Institute of Medical Sciences Raipur
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, newly diagnosed multiple myeloma, anti-CD38 monoclonal antibody, daratumumab, isatuximab, high-risk cytogenetics, minimal residual disease negativity, progression-free survival, transplant eligibility, triplet therapy, Perseus
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7204706653
Cites:
Cited by:
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms